RASHIDA COLEMAN: Open Payments
NPI 1841950268 · HILLSBOROUGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 8 companies in 2025. Trend: 2023 $626 · 2024 $567 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $89 |
| ABBVIE INC. | 3 | $57 |
| Novo Nordisk Inc | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
| Exact Sciences Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, Ozempic, QULIPTA, ELIQUIS, COBENFY, The Cologuard Plus Collection Kit, Kerendia, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
